Silence Therapeutics plc
SLNCF
$1.80
$0.2012.50%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -66.50M | -81.09M | -73.49M | -47.27M | -75.08M |
| Total Depreciation and Amortization | 591.80K | 586.80K | 588.80K | 602.80K | 593.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.01M | 16.85M | 10.19M | 7.94M | 24.00M |
| Change in Net Operating Assets | -11.70M | -23.67M | -8.23M | -29.05M | -4.13M |
| Cash from Operations | -72.61M | -87.32M | -70.95M | -67.78M | -54.61M |
| Capital Expenditure | -120.80K | -181.80K | -218.80K | -214.80K | -149.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 67.79M | -21.58M | -20.03M | -25.56M | -89.09M |
| Cash from Investing | 67.67M | -21.76M | -20.24M | -25.77M | -89.24M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 182.80K | 182.80K | 182.80K | 182.80K | 166.90K |
| Issuance of Common Stock | 15.00K | 7.99M | 9.18M | 142.19M | 153.69M |
| Repurchase of Common Stock | -7.38M | -7.38M | -7.38M | -7.38M | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 8.60M | 8.60M | 8.60M | 8.60M | 861.10K |
| Cash from Financing | 1.41M | 9.38M | 10.58M | 143.58M | 154.72M |
| Foreign Exchange rate Adjustments | 6.85M | 7.23M | 7.01M | 6.75M | 717.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.32M | -92.47M | -73.60M | 56.78M | 11.58M |